Table 1. The high frequency (≥3) covariates adjusted for in multivariate models.
| Description | Slope models | Survival models | Asymptote models |
|---|---|---|---|
| Baseline CD4 count | 13 | 7 | 9 |
| Sex of the participants | 13 | 5 | 8 |
| Age at baseline | 13 | 3 | 9 |
| WHO stage at baseline | 10 | 1 | 1 |
| Type non-nucleoside reverse transcriptase Inhibitor (i.e efavirenze or nevirapine) | 7 | 1 | 2 |
| Initiated on zidovudine at baseline | 6 | 1 | 4 |
| Duration while on antiretroviral therapy | 6 | 0 | 2 |
| Log10 viral load at baseline | 5 | 2 | 3 |
| hemoglobin level at baseline | 5 | 1 | 2 |
| Calendar year of ART start | 4 | 1 | 4 |
| Body Mass Index at baseline | 4 | 1 | 3 |
| Initiated on stavudine at baseline | 4 | 0 | 1 |
| Location of treatment program or clinic | 3 | 3 | 1 |
| Incident tuberculosis diagnosis after ART start | 3 | 3 | 1 |
| History of TB at baseline | 2 | 3 | 0 |
| Antiretroviral therapy adherence | 2 | 1 | 4 |
Notes:
‘Baseline’—Refers to the measurement at ART initiation